期刊文献+

供肝保养液中不同浓度肝素对肝移植术患者新肝期凝血功能的影响 被引量:1

Effects of different concentrations of heparin in the preservation solution on blood coagulation after reperfnsion in patients undergoing orthotopic liver transplantation
原文传递
导出
摘要 目的探讨供肝保养液中不同浓度肝素对肝移植术患者新肝期凝血功能的影响。方法拟行肝移植术的终末期肝病患者40例,随机分为3组,供肝保养液中肝素浓度分别为2 000 U/L(Ⅰ组,n=14)、8 000 U/L(Ⅱ组,n=12)、20 000 U/L(Ⅲ组,n=14)。新肝期前15 min(T0)、新肝期5、30、60、 120、180 min(T1、T2、T3、T4、T5)采中心静脉血,行Sonoclot凝血和血小板功能分析,各组随机测定3-4 例患者血浆肝素浓度(高效液相色谱法)。结果与T0相比,Ⅲ组T1-4时玻璃珠激活凝血时间 (gbACT)均延长,T1-3时血块凝结速率(CR)减慢,T1,2时血小板功能(PF)减小,Ⅱ组T1,2时gbACT延长,T1时CR减慢(P<0.05或0.01),Ⅲ组上述指标的变化较Ⅱ组明显;T1,2时Ⅲ组血浆肝素浓度高于Ⅱ组(P<0.05),Ⅰ组新肝期各时点均未检测到肝素。结论保养液中高浓度肝素可抑制肝移植术患者新肝期凝血功能。 Objective To investigate the effect of different concentrations of heparin in the cold preservation solution on blood coagulation after reperfusion during orthotopic liver transplantation (OLT) . Methods Forty ASA Ⅱ or Ⅲ patients with end-stage liver disease (31 males, 9 females) weighing 51-82 kg undergoing OLT were randomly divided into 3 groups according to the concentrations of heparin in the liver preservation solution: groupⅠ 2000 U·L^-1(n=14); groupⅡ 8000 U·L^-1(n=12) and group Ⅲ 20000 U· L^-1(n= 12). Anesthesia was induced with propofol, fentanyl and rocuronium and maintained with isoflurane inhalation and intermittent i.v. boluses of fentanyl. Body temperature was maintained at 35.5-37.5℃ and Hct at 22%-35%. Blood samples were taken from central vein at 15 min before reperfusion (To ,baseline) and 5, 30, 60, 120 and 180 min of reperfusion (T1-5 ) for determination of ACT, CR and platelet function (PF) using Sonoclot platelet function and coagulation analyzer ( U. S. A. ) . Blood concentration of heparin was determined in 3-4 patients in each group at T0-5 (HPLC) . Results The 3 groups were comparable with respect to age, body weight, ASA physical status and Child classification. The glass ball activated coagulation time (gbACT) was significantly prolonged at T1-4 in group Ⅲ and at T1-2 in group Ⅱ as compared to the baseline values at To ( P 〈 0.05 or 0.01 ). There was no significant difference in gbACT before and after reperfusion in group Ⅰ . In group Ⅲ the rate of clot formation (CR) at T1-3 and PF at T1,2 were significantly decreased as compared to the baseline values at To ( p 〈 0.01 or 0.05). The plasma concentration of heparin at T1,2 was significantly higher in group Ⅲ than in group Ⅱ . No heparin was detected in plasma during reperfusion in group Ⅰ . Conclusion High concentration of heparin in the liver preservation solution significantly affect blood coagulation during reperfusion in OLT.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2006年第4期345-347,共3页 Chinese Journal of Anesthesiology
基金 国家自然科学基金资助项目(39900140)
关键词 肝素 肝移植 血液凝固 Heparin Liver transplantation Blood coagulation
  • 相关文献

参考文献8

  • 1Bellani KG,Estrin JA,Ascher NL,et al.Reperfusion coagulopathy during human liver transplantation.Transplant Proc,1987,19:71-72.
  • 2毛平,黄晓兰,李翠贞,陈蕃,关明媚,蔡小燕,黄润永,陈云华.高效液相色谱法测定血浆肝素含量[J].中华医学检验杂志,1995,18(6):358-360. 被引量:43
  • 3Furuhashi M,Ura N,Hasegawa K,et al.Sonoclot coagulation analysis:new bedside monitoring for determination of the appropriate heparin dose during haemodialysis.Nephrol Dial Transplant,2002,17:1457-1462.
  • 4黄寿吾,傅朝宏,王鸿利.血浆肝素浓度检测的方法和评价[J].上海医学检验杂志,1995,10(1):51-52. 被引量:3
  • 5Kettner SC,Gonano C,Seebach F,et al.Endogenous heparin-like substances significantly impair coagulation in patients undergoing orthotopic liver transplantation.Anesth Analg,1998,86:691-695.
  • 6Montalto P,Vlachogiannakos J,Cox DJ,et al.Bacterial infection in cirrhosis impairs coagulation by a heparin effect:a prospective study.J Hepatol,2002,37:463-470.
  • 7Zambruni A,Thalheimer U,Coppell J,et al.Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients.Scand J Gastroenterol,2004,39:830-836.
  • 8Hambleton J,Leung LL,Levi M.Coagulation:consultative hemostasis.Hematology,2002,:335-353.

二级参考文献3

  • 1毛平,中华医学检验杂志,1995年,18卷,295页
  • 2张昌敬,生物化学杂志,1994年,2卷,50页
  • 3李家增,血栓形成与临床医学,1991年

共引文献44

同被引文献12

  • 1Senzolo M, Cholongitas E, Thalheimer U, et al. Heparin- like Effect in Liver Disease and Liver Transplantation[J]. Clin Liver Dis,2009,13 ( 1 ) :43-53.
  • 2Gouvea G, Toledo R, Diaz R, et al. Protamine Sulphate for Treatment of Severe Post-reperfusion Coagulopathy in Pediatric Liver Transplantation [J]. Pediatr Transplant,2009,13 ( 8 ) : 1053-1057.
  • 3Schlueter A J, Pennell B J, Olson J D. Evaluation of a New Protamine Titration Method to Assay Heparin in Whole Blood and Plasma [J]. Am J Clin Pathol, 1997, 107(5) :511-520.
  • 4Sato Y,Nakatsuka H,Yamamoto S,et al. Coagulation and Fibrinolytic Systems during Liver Regeneration in the Early Period after Adult Living Related Partial Liver Transplantation [J]. Transplant Proc, 2008,40 ( 8 ) : 2501- 2502.
  • 5Juttner B, Brock J, Weissig A, et al. Dependence of Platelet Function on Underlying Liver Disease in Orthotopic Liver Transplantation [J]. Thromb Res, 2009, 124(4) :433-438.
  • 6Dalmau A, Sabate A, Aparieio I. Hemostasis and Coagulation Monitoring and Management during Liver Transplantation[ J ]. Curt Opin Organ Transplant, 2009 , 14(3) :286-290.
  • 7Senzolo M, Riddell A, Tuddenham E, et al. Endogenous Heparinoids Contribute to Coagulopathy in Patients with Liver Disease [J]. J Hepatol, 2008,48 ( 2 ) : 371-372.
  • 8Bakker C M, Stibbe J, Gomes M J, et al. The Appearance of Donor Heparin in the Recipient after Reperfusion of a Liver Graft[ J]. Transplantation, 1993,56:327-329.
  • 9Bayly P J, Thick M. Reversal of Post-reperfusion Coagulopathy by Protamine Sulphate in Orthotopic Liver Transplantation [ J ]. British Journal of Anaesthesia, 1994,73(6) :840-842.
  • 10Chu A J, Wang Z G, Raicu M, et al. Protamine Inhibits Tissue Factor-initiated Extrinsic Coagulation [ J ]. Br J Haematol,2001,115 ( 2 ) :392-399.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部